BRKR
BRUKER CORPPrice
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Mar 13 ▼ 1 insider sell $70.9K at $35.44
- Apr 15 ▼ 1 insider sell $79.8K at $39.90
- May 15 ▼ 1 insider sell $87.8K at $43.90
- Jun 15 ▼ 1 insider sell $109.5K at $54.76
- Jun 30 ▲ 3 funds open new positions (13F)
- Jul 15 ▼ 1 insider sell $120.5K at $60.25
- Aug 4 ▲ Bruker reported Q2 2026 revenue of $838.5M (+5.2% YoY, +2.8% organic…
- Aug 14 to Aug 17 ▼ 2 days of insider sells: $312.8K by 2 insiders, avg $57.16
- Sep 15 ▼ 1 insider sell $105.7K at $52.87
- Oct 14 ▼ JP Morgan downgrades
- Nov 4 ▲ Earnings: BRKR Q3 2026 Earnings: EPS $0.56 (+30.6% vs est)
Signal stack
Where each data set points today.
- InsidersBEARISH
2 insiders sold $887.1K.
- InstitutionsMIXED
Q2 2026: 34 added (3 new), 27 trimmed or exited. Largest new: Sachem Head Capital Management $175.4M, Viking Global Investors $53.8M.
- AnalystsBULLISH
11 of 20 rate it Buy or better. Median target $67.50 (+11%).
- Short sellersSTEADY
Short interest −11.2% to 11.25M shares. 5.4 days to cover, ≈7.4% of shares.
- TrendUPTREND
3% above its 50-day average.
- SocialQUIET
Crowd 60° (warm) this week from 1 mention: 1 bullish, 0 bearish. No setup is alerting.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| FMR LLC | ADD | $1.2B |
| Sculptor Capital LP | ADD | $278.3M |
| Sachem Head Capital Management LP | NEW | $175.4M |
| FIRST TRUST ADVISORS LP | ADD | $124.3M |
| Alyeska Investment Group, L.P. | ADD | $84.9M |
| GOLDMAN SACHS GROUP INC | DOUBLED | $68.8M |
| M&G Plc | TRIM | $67.5M |
| VIKING GLOBAL INVESTORS LP | NEW | $53.8M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
20 analystsPrice is inside the target range. Median implies +11%.Targets as of Nov 16, 2026.
| Date | Firm | Rating |
|---|---|---|
| Nov 5, 2026 | Citigroup MAINTAIN | Neutral |
| Nov 5, 2026 | Leerink Partners MAINTAIN | Outperform |
| Oct 14, 2026 | JP Morgan DOWNGRADE | Neutral |
| Oct 13, 2026 | TD Cowen MAINTAIN | Hold |
| Oct 7, 2026 | Barclays MAINTAIN | Overweight |
| Oct 1, 2026 | Guggenheim MAINTAIN | Buy |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Munch Mark EXEC VP&PRES BRUKER NANO INC. Sep 15, 2026 | EXERCISE | $44.4K |
Munch Mark EXEC VP&PRES BRUKER NANO INC. Sep 15, 2026 | SELL | $105.7K |
Pusch Wolfgang President BMID Group Aug 17, 2026 | SELL | $197.6K |
Srega Juergen PRESIDENT CALID Aug 15, 2026 | AWARD | 16,898 sh |
LAUKIEN FRANK H PRESIDENT & CEO Aug 15, 2026 | TAX W/H | $274.7K |
Herman Gerald N EXECUTIVE VICE PRESIDENT, CFO Aug 15, 2026 | TAX W/H | $157.2K |
Bures Thomas Chief Accounting Officer Aug 15, 2026 | AWARD | 4,035 sh |
Munch Mark EXEC VP&PRES BRUKER NANO INC. Aug 15, 2026 | AWARD | 14,443 sh |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 30, 2026SecBot reports
10 filings · 1 bullish · 0 bearish · 2 mixed · 7 neutral- NEUTRAL 8-KNov 16, 2026
Bruker appointed Dr. Eicke Latz to its Board of Directors effective January 1, 2027, and declared a quarterly cash dividend of $0.05 per share payable January 7, 2027. Both items are routine governance and capital allocation actions with no material financial impact.
🔒 Fresh report (last 24h), subscribers only
- NEUTRAL INST-CLUSTERNov 6, 2026
Institutional activity in BRKR during Q3 2026 was mixed: four small asset managers added positions…
The cluster shows a net selling bias driven by one large seller (M&G), while smaller buyers added modestly. Monitor next 13F for whether M&G's exit continues and if any activist or hedge fund…
- NEUTRAL 8-KNov 5, 2026
Bruker filed an 8-K to disclose a reorganization of its reportable segments effective July 1…
Monitor upcoming 10-Q for Q3 2026 to see the first full quarter of results under the new segment structure, particularly BSI BIOS and BSI BMID margins.
- NEUTRAL 8-KNov 4, 2026
Bruker reported Q3 2026 revenue of $874.0M (+1.6% YoY) and non-GAAP EPS of $0.56 (+24.4% YoY)…
The beat was driven by margin expansion and cost discipline rather than revenue acceleration. With organic revenue growth of only 0.7% and BSI organic revenue declining 0.4%, the top-line story…
All BRKR filing & press-release reports (10)
- 8-K reportNov 16, 2026
- INST-CLUSTER reportNov 6, 2026
- 8-K reportNov 5, 2026
- 8-K reportNov 4, 2026
- 8-K reportOct 29, 2026
- INST-CLUSTER reportOct 27, 2026
- CLUSTER reportAug 18, 2026
- 8-K reportAug 14, 2026
- 8-K reportAug 4, 2026
- INST-CLUSTER reportJun 11, 2026